ST
₹1,097.50
+11.90(+1.10%)
STAR₹1,097.50+1.10%
67/100
0100 · strongest
good
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %STAR financial summary
For Mar 2026, Strides Pharma Science Limited reported revenue of ₹2,180 crore, which grew 1.9% from the previous year. Net profit was ₹184 crore, which fell 93.6% year on year, on an operating margin of 13%. Earnings per share came in at ₹19.92. Annual results are available for 14 financial years, from Dec 2012 to Mar 2026.
| Revenue | ₹2,180 crore |
|---|---|
| Net profit | ₹184 crore |
| Operating margin | 13% |
| EPS | ₹19.92 |